70% of APIs under development are poorly water soluble which increases the risk of them failing during formulation. Co-crystallization is a rapidly growing technique used to tackle solubility challenges. However, it is challenging and resource intensive to find new co-crystals experimentally.
In recent years, several approaches have been developed to screen for co-crystals computationally. We developed mPredict™, a co-crystal prediction tool with quantum chemistry, statistical thermodynamics, and AI. It predicts co-crystal formation and, hence, optimal co-formers for your API. Besides being a strong improvement over physical modeling, it is also three times faster than random digital screening.
In this webinar, you will learn:
- That co-crystallization is rapidly growing as a technique to tackle solubility challenges
- About the challenges of co-crystallization and ways to overcome them
- What are the key technical considerations to build an AI based co-former screening tool
- About the advantages of using our cutting edge mPredict™ co-crystal prediction service
Speakers

Mitali Bhagwat
Merck
Strategic Product Manager – Excipients Solid Application
Mitali is a strategic product manager in the field of excipients used for solid formulation drug development and is leading the group's digital strategy with its flagship product mPredict™. Mitali has a master's degree in pharmaceutical sciences and almost 10 years of work experience in the industry around product development and IP strategies. After completing her MBA in international management and working as a management consultant in the industry, her ambition now is to bring drug formulation closer to digital / AI technologies.

Rimson Muara Jaya
Merck
Customer Application Expert SEATWO
Rimson is a technical application expert, specializing in small to large molecules. Rimson holds a pharmacist's degree and a master's in business administration. He has more than 10 years of extensive experience in the pharmaceutical industry, with a strong focus on project management, production, and GMP assurance for various small molecule pharmaceutical dosage forms.
Pharma and biopharma manufacturing
- Solid Formulation Strategies
Duration:1h
語言:English
會話 1:提出 January 14, 2025
若要繼續閱讀,請登入或建立帳戶。
還沒有帳戶?